NSPR Stock Summary and Trading Ideas (Inspiremd | NASDAQ:NSPR)

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Inspiremd trades on the NASDAQ stock market under the symbol NSPR.

As of July 2, 2024, NSPR stock price was flat at $2.44 with 46 million shares trading.

NSPR has a beta of 1.50, meaning it tends to be more sensitive to market movements. NSPR has a correlation of 0.08 to the broad based SPY ETF.

NSPR has a market cap of $60.83 million. This is considered a Micro Cap stock.

Last quarter Inspiremd reported $2 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $131,000 and missed earnings estimates by -$.06.

In the last 3 years, NSPR stock traded as high as $6.82 and as low as $.81.

NSPR has underperformed the market in the last year with a price return of -2.8% while the SPY ETF gained +24.5%. NSPR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.1% and -2.0%, respectively, while the SPY returned +4.7% and -0.1%, respectively.

NSPR support price is $2.34 and resistance is $2.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NSPR stock will trade within this expected range on the day.